84 related articles for article (PubMed ID: 1243595)
1. HL-A antigens in Japanese Patients with Graves' disease.
Grumet FC; Payne RO; Konishi J; Mori T; Kriss JP
Tissue Antigens; 1975 Nov; 6(5):347-52. PubMed ID: 1243595
[TBL] [Abstract][Full Text] [Related]
2. [Human leukocyte antigen (HLA) complex and anti-thyroidal antibodies in Graves' disease].
Lacka K; Kordel M; Gembicki M
Pol Tyg Lek; 1989 Feb 13-20; 44(7-8):179-81. PubMed ID: 2682567
[TBL] [Abstract][Full Text] [Related]
3. HLA antigens in Japanese patients with Graves' disease and Hashimoto's disease [proceedings].
Konishi J; Grumet FC; Payne RO; Mori T; Kriss JP
Diabete Metab; 1976 Sep; 2(3):163-4. PubMed ID: 1036991
[No Abstract] [Full Text] [Related]
4. Peripheral blood T lymphocyte sensitization to thyroid microsomal antigen from patients with Graves' disease negative for circulating anti-thyroid microsomal antibodies.
Matsubayashi S; Sakatsume Y; Kasuga Y; Akasu F; Tamai H; Volpé R
Clin Invest Med; 1990 Dec; 13(6):339-42. PubMed ID: 2078913
[TBL] [Abstract][Full Text] [Related]
5. Association of HLA antigen BW35 with severe Graves' ophthalmopathy.
Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ; Sanford CA
Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):124-7. PubMed ID: 6600737
[TBL] [Abstract][Full Text] [Related]
6. [Study of the HL-A system in Basedow's disease (author's transl)].
Jaffiol C; Seignalet J; Baldet L; Robin M; Lapinski H; Mirouze J
Ann Endocrinol (Paris); 1976; 37(2):111-2. PubMed ID: 1036872
[TBL] [Abstract][Full Text] [Related]
7. Prediction of outcome in Graves' disease after carbimazole treatment.
Weetman AP; Ratanachaiyavong S; Middleton GW; Love W; John R; Owen GM; Darke C; Lazarus JH; Hall R; McGregor AM
Q J Med; 1986 Apr; 59(228):409-19. PubMed ID: 2875484
[TBL] [Abstract][Full Text] [Related]
8. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R
Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555
[TBL] [Abstract][Full Text] [Related]
9. The interaction of MHC and Gm in liability to autoimmune thyroid disease.
Nagataki S
Mol Biol Med; 1986 Feb; 3(1):73-84. PubMed ID: 3007922
[TBL] [Abstract][Full Text] [Related]
10. Increased activated T-lymphocytes and normal thyrotropin receptor antibody levels in Graves' disease in long-term remission.
Peakman M; Hussain M; Cundy T; Vergani D
J Clin Lab Immunol; 1989 Sep; 30(1):1-5. PubMed ID: 2577115
[TBL] [Abstract][Full Text] [Related]
11. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
Molnár I; Balázs C
Acta Med Hung; 1991; 48(1-2):13-21. PubMed ID: 1813853
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.
Frecker MF; Preus M; Kozma L; Krasrits E; Stenszky V; Balazś C; Farid NR
Mol Biol Med; 1986 Feb; 3(1):63-71. PubMed ID: 3083192
[TBL] [Abstract][Full Text] [Related]
13. Thyroglobulin antibodies in Graves' disease are associated with T-cell receptor beta chain and major histocompatibility complex loci.
Demaine AG; Ratanachaiyavong S; Pope R; Ewins D; Millward BA; McGregor AM
Clin Exp Immunol; 1989 Jul; 77(1):21-4. PubMed ID: 2569950
[TBL] [Abstract][Full Text] [Related]
14. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese.
Kamizono S; Hiromatsu Y; Seki N; Bednarczuk T; Matsumoto H; Kimura A; Itoh K
Clin Endocrinol (Oxf); 2000 Jun; 52(6):759-64. PubMed ID: 10848881
[TBL] [Abstract][Full Text] [Related]
15. The role of HLA antigens in the manifestation and course of Graves' disease.
Stenszky V; Kozma L; Balazś C; Bear JC; Farid NR
Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758
[TBL] [Abstract][Full Text] [Related]
16. Studies of possible antiidiotypic control mechanisms in Graves' disease.
Moynier M; Montano J; Williams RC; Pathak D; DeGroot LC; Hill BL; Marshall NJ
J Lab Clin Med; 1988 Jul; 112(1):99-108. PubMed ID: 2839588
[TBL] [Abstract][Full Text] [Related]
17. [Graves' disease. Predominance of the DRw3 antigen (author's transl)].
Allanic H; Fauchet R; Lorcy Y; Heim J; Guéguen M; Leguerrier AM; Genetet B
Nouv Presse Med; 1980 Jun; 9(26):1823-6. PubMed ID: 6893077
[TBL] [Abstract][Full Text] [Related]
18. Histocompatibility antigens in Graves' disease.
Ford D; Knight JG; Reeve JK; Stewart RD
Aust N Z J Med; 1976 Aug; 6(4):297-9. PubMed ID: 1070984
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of the fourth component of complement in Graves' disease and type I diabetes mellitus.
Skanes V; Larsen B; Sampson-Murphy L; Farid NR
Clin Invest Med; 1985; 8(2):126-32. PubMed ID: 3869086
[TBL] [Abstract][Full Text] [Related]
20. HL-A in Graves' disease and in diabetes mellitus insulin-dependent.
Seignalet J; Mirouze J; Jaffiol C; Selam JL; Lapinski H
Tissue Antigens; 1975 Oct; 6(4):272-4. PubMed ID: 1242826
[No Abstract] [Full Text] [Related]
[Next] [New Search]
